Categories: IFHInova in the News

Uterine Cancer Rates on the Rise, Cancer Today, January 4, 2016

G. Larry Maxwell, a gynecologic oncologist at Inova Fairfax Hospital in Falls Church, Virginia, whose research includes studies on racial disparities, agrees that biology could be a factor. “The aggressive tumors seen in African-American women seem to be more resistant to chemotherapy,” says Maxwell, “and they appear to have differences in response to treatment.” He noted that there may also be social or cultural factors unique to African-American women that contribute to the types of tumors they develop.

Maxwell says all women should talk to their doctors about what they can do to reduce their risk of endometrial cancer through diet, exercise and stress reduction. There is no screening test for endometrial cancer, so if women have symptoms of the disease, Maxwell says, “they need to see a gynecologist immediately.” Read more.

InovaNewsroom

Share
Published by
InovaNewsroom

Recent Posts

The most important heart disease risk test you’ve never heard of

What is hsCRP, and how can it help predict your risk of developing heart disease?…

1 day ago

Inova continues to set the national standard for excellence in health care

Recognition from U.S. News & World Report, Modern Healthcare and Press Ganey highlights Inova's commitment…

1 week ago

Inova appoints Susan Carroll as Chief, Clinical Enterprise Operations   

Raj Chand, MD, to serve as Interim President, Inova Loudoun Hospital  Fairfax, VA — Inova is pleased to announce…

2 weeks ago

Inova first in Virginia and Mid-Atlantic to use advanced fluorescent imaging technology to improve ovarian cancer surgery

FDA-approved technology helps surgeons visualize ovarian cancer in real time during surgery FAIRFAX, Va. –…

3 weeks ago

Inova Loudoun Mobile Health Services: August 2026

Leesburg, VA — Inova Loudoun Hospital Mobile Health Services will be providing countywide blood pressure…

3 weeks ago

Inova Schar Cancer’s pulmonary nodule program saves lives

Study at a glanceInova’s incidental lung nodule program has shown a 76% reduction in time…

3 weeks ago